{"id":130884,"date":"2026-06-25T13:02:34","date_gmt":"2026-06-25T07:32:34","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=130884"},"modified":"2026-06-25T13:02:35","modified_gmt":"2026-06-25T07:32:35","slug":"abbott-india-q1-results-fy27","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/","title":{"rendered":"Abbott India Q1 Results FY27: Uniresearch Prediction and Analysis"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Abbott India Q1 Results FY27: Uniresearch projects Revenue Rs 1,939 Cr | PAT Rs 408 Cr (Uniresearch trailing analysis). Q4 FY26: Rev Rs 1,710 Cr | PAT Rs 395 Cr.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\">Abbott India<\/a> Q1 Results FY27 outlook from Uniresearch is anchored on verified Q4 FY26 actuals and Uniresearch trailing analysis. Uniresearch projects Abbott India Q1 FY27 Revenue Rs 1,939 Cr (+11.6% YoY) and PAT Rs 408 Cr (+11.6% YoY). Prepared by Ankit Jaiswal.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=abbott-india-q1-results-fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#Abbott_India_Q1_Results_FY27_%E2%80%93_Uniresearch_Prediction\" title=\"Abbott India Q1 Results FY27 &#8211; Uniresearch Prediction\">Abbott India Q1 Results FY27 &#8211; Uniresearch Prediction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#Abbott_India_Q4_FY26_Performance\" title=\"Abbott India Q4 FY26 Performance\">Abbott India Q4 FY26 Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#Analyst_Views_and_Growth_Outlook\" title=\"Analyst Views and Growth Outlook\">Analyst Views and Growth Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#Key_Watchpoints\" title=\"Key Watchpoints\">Key Watchpoints<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#Revenue_Delivery\" title=\"Revenue Delivery\">Revenue Delivery<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#PAT_vs_Growth_Target\" title=\"PAT vs Growth Target\">PAT vs Growth Target<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#Risks\" title=\"Risks\">Risks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#Revenue_Shortfall\" title=\"Revenue Shortfall\">Revenue Shortfall<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#Margin_Pressure\" title=\"Margin Pressure\">Margin Pressure<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#FAQs_on_Abbott_India_Q1_Results_FY27\" title=\"FAQs on Abbott India Q1 Results FY27\">FAQs on Abbott India Q1 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#What_is_Uniresearchs_PAT_prediction_for_Abbott_India_Q1_Results_FY27\" title=\"What is Uniresearch&#8217;s PAT prediction for Abbott India Q1 Results FY27?\">What is Uniresearch&#8217;s PAT prediction for Abbott India Q1 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#What_is_the_Revenue_forecast_for_Abbott_India_Q1_Results_FY27\" title=\"What is the Revenue forecast for Abbott India Q1 Results FY27?\">What is the Revenue forecast for Abbott India Q1 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#What_were_Abbott_India_Q4_FY26_actuals_for_Abbott_India_Q1_Results_FY27\" title=\"What were Abbott India Q4 FY26 actuals for Abbott India Q1 Results FY27?\">What were Abbott India Q4 FY26 actuals for Abbott India Q1 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#How_many_analysts_cover_Abbott_India_Q1_Results_FY27\" title=\"How many analysts cover Abbott India Q1 Results FY27?\">How many analysts cover Abbott India Q1 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#What_consensus_applies_to_Abbott_India_Q1_Results_FY27\" title=\"What consensus applies to Abbott India Q1 Results FY27?\">What consensus applies to Abbott India Q1 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#What_are_the_main_risks_to_Abbott_India_Q1_Results_FY27\" title=\"What are the main risks to Abbott India Q1 Results FY27?\">What are the main risks to Abbott India Q1 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q1-results-fy27\/#What_is_the_Q1_FY26_base_for_Abbott_India_Q1_Results_FY27\" title=\"What is the Q1 FY26 base for Abbott India Q1 Results FY27?\">What is the Q1 FY26 base for Abbott India Q1 Results FY27?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Abbott_India_Q1_Results_FY27_%E2%80%93_Uniresearch_Prediction\"><\/span><strong>Abbott India Q1 Results FY27 &#8211; Uniresearch Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px; margin: 16px 0;\">\n<tbody>\n<tr>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Metric<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Q1 FY26 Actual<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Q1 FY27 Uniresearch Prediction<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>YoY Change<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Source<\/strong><\/th>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\"><a href=\"https:\/\/univest.in\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\">Abbott India<\/a> Revenue (Rs Cr)<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">1,738<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">1,939<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">+11.6%<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Uniresearch | Uniresearch trailing analysis<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">PAT (Rs Cr)<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">366<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">408<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">+11.6%<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Uniresearch | Uniresearch trailing analysis<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Avg Analyst Target<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">See screener<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">12-month view<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">&#8211;<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Uniresearch trailing analysis<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Abbott_India_Q4_FY26_Performance\"><\/span><strong>Abbott India Q4 FY26 Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px; margin: 16px 0;\">\n<tbody>\n<tr>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Metric<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Q4 FY26 Actual<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>vs Q1 FY26<\/strong><\/th>\n<th style=\"border: 1px solid #D0D7E2; padding: 9px 14px; background: #EBF3FB;\"><strong>Source<\/strong><\/th>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Revenue (Rs Cr)<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">1,710<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">-1.6%<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Screener consolidated<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">PAT (Rs Cr)<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">395<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">+7.9%<\/td>\n<td style=\"border: 1px solid #D0D7E2; padding: 9px 14px;\">Screener consolidated<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Views_and_Growth_Outlook\"><\/span><strong>Analyst Views and Growth Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Uniresearch trailing analysis projects Abbott India FY27 revenue at +11.6% and profit at +11.6% YoY. Uniresearch applied these growth rates to Q1 FY26 actuals to derive the Q1 FY27 prediction. Q4 FY26 actuals showed Abbott India delivering revenue of Rs 1,710 Cr and PAT of Rs 395 Cr.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Watchpoints\"><\/span><strong>Key Watchpoints<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Delivery\"><\/span><strong>Revenue Delivery<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key question: can Abbott India reach Rs 1,939 Cr in Q1 FY27 revenue, representing +11.6% YoY growth over the Q1 FY26 base of Rs 1,738 Cr.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"PAT_vs_Growth_Target\"><\/span><strong>PAT vs Growth Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Profit performance of Rs 408 Cr (+11.6%) vs the Q1 FY26 base of Rs 366 Cr is the profitability watchpoint for Abbott India in Q1 FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks\"><\/span><strong>Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Shortfall\"><\/span><strong>Revenue Shortfall<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Revenue below the +11.6% consensus would indicate sector headwinds or execution delays for Abbott India.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Margin_Pressure\"><\/span><strong>Margin Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Cost increases or margin compression could challenge the +11.6% PAT growth projection for Abbott India in Q1 FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Abbott India Q1 FY27 Uniresearch projection of Revenue Rs 1,939 Cr and PAT Rs 408 Cr is derived from the Uniresearch trailing analysis. Investors should watch Q4 FY26 actuals as the base, and track Abbott India live on the Univest Screener.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Track Abbott India Live on the Univest Screener<\/strong><\/a><\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> for live FY27 alerts.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions are derived by applying analyst consensus growth rates to verified Q1 FY26 actuals. These are projections, not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Abbott_India_Q1_Results_FY27\"><\/span><strong>FAQs on Abbott India Q1 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Uniresearchs_PAT_prediction_for_Abbott_India_Q1_Results_FY27\"><\/span><strong>What is Uniresearch&#8217;s PAT prediction for Abbott India Q1 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Uniresearch projects Abbott India Q1 FY27 PAT at Rs 408 Cr (+11.6% vs Q1 FY26 base Rs 366 Cr).<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Revenue_forecast_for_Abbott_India_Q1_Results_FY27\"><\/span><strong>What is the Revenue forecast for Abbott India Q1 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Abbott India Q1 FY27 Revenue is projected at Rs 1,939 Cr (+11.6% consensus).<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Abbott_India_Q4_FY26_actuals_for_Abbott_India_Q1_Results_FY27\"><\/span><strong>What were Abbott India Q4 FY26 actuals for Abbott India Q1 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Q4 FY26 Revenue Rs 1,710 Cr and PAT Rs 395 Cr.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_analysts_cover_Abbott_India_Q1_Results_FY27\"><\/span><strong>How many analysts cover Abbott India Q1 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The prediction uses Uniresearch trailing analysis, avg target Rs 0.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_consensus_applies_to_Abbott_India_Q1_Results_FY27\"><\/span><strong>What consensus applies to Abbott India Q1 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue +11.6% and profit +11.6% (Uniresearch trailing analysis).<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_risks_to_Abbott_India_Q1_Results_FY27\"><\/span><strong>What are the main risks to Abbott India Q1 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue missing +11.6% consensus and PAT pressure vs +11.6% growth target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Q1_FY26_base_for_Abbott_India_Q1_Results_FY27\"><\/span><strong>What is the Q1 FY26 base for Abbott India Q1 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Q1 FY26 Revenue Rs 1,738 Cr and PAT Rs 366 Cr.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Abbott India Q1 FY27: Rev Rs 1,939 Cr (+11.6%) PAT Rs 408 Cr (+11.6%) | Uniresearch trailing analysis.<\/p>\n","protected":false},"author":35,"featured_media":131087,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-130884","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782372761:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["80"],"rank_math_title":["Abbott India Q1 Results FY27: Uniresearch Predictions and Analyst"],"rank_math_description":["Abbott India Q1 Results FY27: Uniresearch projects Q1 FY27 Revenue Rs 1,939 Cr and PAT Rs 408 Cr (Uniresearch trailing analysis). Q4 FY26 actuals inside."],"rank_math_focus_keyword":["Abbott India Q1 Results FY27"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["131087"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["21231"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Abbott-India-Q1-Results-FY27-Uniresearch-Prediction-and-Analysis.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/130884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=130884"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/130884\/revisions"}],"predecessor-version":[{"id":131090,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/130884\/revisions\/131090"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/131087"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=130884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=130884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=130884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}